Literature DB >> 25163801

The miRNA network: micro-regulator of cell signaling in cancer.

Qian Mei1, Xiang Li, Mingzhou Guo, Xiaobing Fu, Weidong Han.   

Abstract

The dysregulation of cell signaling plays a pivotal role in tumorigenesis and progression. miRNAs have been linked to almost all known aspects of physiological and pathological processes. It is well known that the miRNA network is linked at several and unexpected levels with cancer-related signaling pathways. Our understanding of the roles and regulation of the miRNA network has been extended to include classical cell signaling, termed miRNA network complements cell signaling in cancer. As a transcription factor, tumor suppressor p53 plays a central role in tumor prevention. Recent studies have demonstrated that miRNAs may regulate the expression of the p53 pathway or be regulated by the p53 pathway. These findings added a new and challenging layer of complexity to the p53 pathway and prompted us to contemplate the use of the compensatory mechanisms in therapeutics against cancer. In this review, we have therefore summarized the p53 tumor suppressive pathway as a typical paradigm to elucidate the advances of the compensatory mechanisms. We then go on to critically discuss how the compensatory mechanisms can be used to enable better cancer diagnosis and prognosis and to serve as potential therapeutic targets.

Entities:  

Keywords:  cell signaling; gene regulation; miRNAs; p53 pathway; prognosis; tumorigenesis

Mesh:

Substances:

Year:  2014        PMID: 25163801     DOI: 10.1586/14737140.2014.953935

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN: 1473-7140            Impact factor:   4.512


  12 in total

1.  CRCT1 regulated by microRNA-520 g inhibits proliferation and induces apoptosis in esophageal squamous cell cancer.

Authors:  Ning Wu; Yang Song; Liewen Pang; Zhiming Chen
Journal:  Tumour Biol       Date:  2015-12-30

2.  MicroRNA-877 acts as a tumor suppressor by directly targeting eEF2K in renal cell carcinoma.

Authors:  Qianqian Shi; Xianlin Xu; Qing Liu; Fengbao Luo; Jian Shi; Xiaozhou He
Journal:  Oncol Lett       Date:  2015-12-31       Impact factor: 2.967

Review 3.  Circulating miR-21 as a Potential Biomarker for the Diagnosis of Oral Cancer: A Systematic Review with Meta-Analysis.

Authors:  Mario Dioguardi; Giorgia Apollonia Caloro; Luigi Laino; Mario Alovisi; Diego Sovereto; Vito Crincoli; Riccardo Aiuto; Erminia Coccia; Giuseppe Troiano; Lorenzo Lo Muzio
Journal:  Cancers (Basel)       Date:  2020-04-10       Impact factor: 6.639

Review 4.  MicroRNAs: Novel immunotherapeutic targets in colorectal carcinoma.

Authors:  Xiang Li; Jing Nie; Qian Mei; Wei-Dong Han
Journal:  World J Gastroenterol       Date:  2016-06-21       Impact factor: 5.742

Review 5.  Targeting MicroRNA in Cancer Using Plant-Based Proanthocyanidins.

Authors:  Rishipal R Bansode; Janak R Khatiwada; Jack N Losso; Leonard L Williams
Journal:  Diseases       Date:  2016-04-28

6.  miR-21-5p induces cell proliferation by targeting TGFBI in non-small cell lung cancer cells.

Authors:  Liang Yan; Jinzhu Ma; Yi Wang; Jiawei Zan; Zhen Wang; Yu Zhu; Yiping Zhu; Liefeng Ling; Long Cao; Xin Liu; Shu Li; Lei Xu; Zhilin Qi; Liuwang Nie; Yao Zhang
Journal:  Exp Ther Med       Date:  2018-09-18       Impact factor: 2.447

Review 7.  Methodological Approaches to Study Extracellular Vesicle miRNAs in Epstein⁻Barr Virus-Associated Cancers.

Authors:  Li Sun; David G Meckes
Journal:  Int J Mol Sci       Date:  2018-09-18       Impact factor: 5.923

8.  Phase Ib/II study of safety and efficacy of low-dose decitabine-primed chemoimmunotherapy in patients with drug-resistant relapsed/refractory alimentary tract cancer.

Authors:  Meixia Chen; Jing Nie; Yang Liu; Xiang Li; Yan Zhang; Malcolm V Brock; Kaichao Feng; Zhiqiang Wu; Xiaolei Li; Lu Shi; Suxia Li; Mingzhou Guo; Qian Mei; Weidong Han
Journal:  Int J Cancer       Date:  2018-04-26       Impact factor: 7.396

9.  MiR-542-5p is a negative prognostic factor and promotes osteosarcoma tumorigenesis by targeting HUWE1.

Authors:  Dong-dong Cheng; Tao Yu; Tu Hu; Ming Yao; Cun-yi Fan; Qing-cheng Yang
Journal:  Oncotarget       Date:  2015-12-15

10.  MicroRNA-488 inhibits proliferation, invasion and EMT in osteosarcoma cell lines by targeting aquaporin 3.

Authors:  Jing Qiu; Yongzhi Zhang; Hu Chen; Zhi Guo
Journal:  Int J Oncol       Date:  2018-07-16       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.